375 related articles for article (PubMed ID: 21807996)
1. Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome.
Kim KY; Hysolli E; Park IH
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14169-74. PubMed ID: 21807996
[TBL] [Abstract][Full Text] [Related]
2. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation.
Cheung AY; Horvath LM; Grafodatskaya D; Pasceri P; Weksberg R; Hotta A; Carrel L; Ellis J
Hum Mol Genet; 2011 Jun; 20(11):2103-15. PubMed ID: 21372149
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation in pluripotent stem cells by methyl CpG-binding protein 2 (MeCP2).
Tanaka Y; Kim KY; Zhong M; Pan X; Weissman SM; Park IH
Hum Mol Genet; 2014 Feb; 23(4):1045-55. PubMed ID: 24129406
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage.
Andoh-Noda T; Akamatsu W; Miyake K; Matsumoto T; Yamaguchi R; Sanosaka T; Okada Y; Kobayashi T; Ohyama M; Nakashima K; Kurosawa H; Kubota T; Okano H
Mol Brain; 2015 May; 8():31. PubMed ID: 26012557
[TBL] [Abstract][Full Text] [Related]
5. Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2.
Chen X; Han X; Blanchi B; Guan W; Ge W; Yu YC; Sun YE
Protein Cell; 2021 Aug; 12(8):639-652. PubMed ID: 32851591
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Rett syndrome using pluripotent stem cells.
Dajani R; Koo SE; Sullivan GJ; Park IH
J Cell Biochem; 2013 Nov; 114(11):2446-53. PubMed ID: 23744605
[TBL] [Abstract][Full Text] [Related]
7. Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model.
Ananiev G; Williams EC; Li H; Chang Q
PLoS One; 2011; 6(9):e25255. PubMed ID: 21966470
[TBL] [Abstract][Full Text] [Related]
8. Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations.
Chapleau CA; Calfa GD; Lane MC; Albertson AJ; Larimore JL; Kudo S; Armstrong DL; Percy AK; Pozzo-Miller L
Neurobiol Dis; 2009 Aug; 35(2):219-33. PubMed ID: 19442733
[TBL] [Abstract][Full Text] [Related]
9. WGCNA Identifies Translational and Proteasome-Ubiquitin Dysfunction in Rett Syndrome.
Haase F; Gloss BS; Tam PPL; Gold WA
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576118
[TBL] [Abstract][Full Text] [Related]
10. Modeling Rett Syndrome with Human Pluripotent Stem Cells: Mechanistic Outcomes and Future Clinical Perspectives.
Gomes AR; Fernandes TG; Cabral JMS; Diogo MM
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916879
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological reactivation of inactive X-linked
Przanowski P; Wasko U; Zheng Z; Yu J; Sherman R; Zhu LJ; McConnell MJ; Tushir-Singh J; Green MR; Bhatnagar S
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7991-7996. PubMed ID: 30012595
[TBL] [Abstract][Full Text] [Related]
12. Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations.
Farra N; Zhang WB; Pasceri P; Eubanks JH; Salter MW; Ellis J
Mol Psychiatry; 2012 Dec; 17(12):1261-71. PubMed ID: 22230884
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomic analysis of Rett iPSC-derived neuronal progenitors.
Varderidou-Minasian S; Hinz L; Hagemans D; Posthuma D; Altelaar M; Heine VM
Mol Autism; 2020 May; 11(1):38. PubMed ID: 32460858
[TBL] [Abstract][Full Text] [Related]
14. Normalized Clinical Severity Scores Reveal a Correlation between X Chromosome Inactivation and Disease Severity in Rett Syndrome.
Merritt JK; Fang X; Caylor RC; Skinner SA; Friez MJ; Percy AK; Neul JL
Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790223
[TBL] [Abstract][Full Text] [Related]
15. Modeling Rett Syndrome Using Human Induced Pluripotent Stem Cells.
Andoh-Noda T; Inouye MO; Miyake K; Kubota T; Okano H; Akamatsu W
CNS Neurol Disord Drug Targets; 2016; 15(5):544-50. PubMed ID: 27071793
[TBL] [Abstract][Full Text] [Related]
16. IGF1 neuronal response in the absence of MECP2 is dependent on TRalpha 3.
de Souza JS; Carromeu C; Torres LB; Araujo BH; Cugola FR; Maciel RM; Muotri AR; Giannocco G
Hum Mol Genet; 2017 Jan; 26(2):270-281. PubMed ID: 28007906
[TBL] [Abstract][Full Text] [Related]
17. Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons.
Williams EC; Zhong X; Mohamed A; Li R; Liu Y; Dong Q; Ananiev GE; Mok JC; Lin BR; Lu J; Chiao C; Cherney R; Li H; Zhang SC; Chang Q
Hum Mol Genet; 2014 Jun; 23(11):2968-80. PubMed ID: 24419315
[TBL] [Abstract][Full Text] [Related]
18. Generation of Isogenic Controls for In Vitro Disease Modelling of X-Chromosomal Disorders.
Hinz L; Hoekstra SD; Watanabe K; Posthuma D; Heine VM
Stem Cell Rev Rep; 2019 Apr; 15(2):276-285. PubMed ID: 30421281
[TBL] [Abstract][Full Text] [Related]
19. Rett syndrome and MeCP2.
Liyanage VR; Rastegar M
Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633
[TBL] [Abstract][Full Text] [Related]
20. Two new Rett syndrome families and review of the literature: expanding the knowledge of MECP2 frameshift mutations.
Ravn K; Roende G; Duno M; Fuglsang K; Eiklid KL; Tümer Z; Nielsen JB; Skjeldal OH
Orphanet J Rare Dis; 2011 Aug; 6():58. PubMed ID: 21878110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
